Genomics

Dataset Information

0

Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade

ABSTRACT: PIPAC

PROVIDER: PRJEB73724 | ENA |

REPOSITORIES: ENA

Json Xml

Similar Datasets

Unknown Treatment of peritoneal metastases from colorectal cancer.
| S-EPMC4650975 | biostudies-literature
Unknown UK trial of pressurised intraperitoneal aerosolised chemotherapy (PIPAC) with oxaliplatin for colorectal cancer peritoneal metastases (NCT03868228).
| S-EPMC10739292 | biostudies-literature
Unknown Liver metastases and peritoneal metastases and response to checkpoint inhibitors in metastatic colorectal cancer with microsatellite instability.
| S-EPMC11630756 | biostudies-literature
Unknown Predictive Genetic Biomarkers for the Development of Peritoneal Metastases in Colorectal Cancer.
| S-EPMC10454220 | biostudies-literature
Unknown Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic review.
| S-EPMC8100707 | biostudies-literature
Unknown Colorectal peritoneal metastases: Optimal management review.
| S-EPMC6658395 | biostudies-literature
Unknown CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases.
| S-EPMC11874311 | biostudies-literature
Unknown Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment.
| S-EPMC9117473 | biostudies-literature
Unknown Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity.
| S-EPMC9174226 | biostudies-literature
Unknown Treatment Response After Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases of Colorectal Originf.
| S-EPMC10406066 | biostudies-literature